Company: 
About
Polen brings more than 25 years of experience in medical technology. He started at BD in 1999 through the acquisition of an early phase start-up. In 2004, he joined Baxter Healthcare, where he led the injectable pharmaceuticals business. Since returning to BD in 2009, Polen has served in a variety of leadership roles, including as president of several worldwide business units within BD’s Life Sciences segment and later as president of the BD Medical segment, during which he led the $12 billion acquisition of CareFusion, spearheading the company’s expansion into informatics and digital health solutions. In 2017, he led the strategy for the $24 billion acquisition of C. R. Bard, Inc. and shortly thereafter was named president and chief operating officer of BD. Polen became CEO in January 2020 and chairman of the board of directors in April 2021. Polen serves on the board of directors of Advamed and Hackensack Meridian Health Center for Discovery and Innovation. He is a member of the American Heart Association CEO Roundtable and actively supports the Children’s Tumor Foundation, as well as several associations committed to helping patients with breast cancer. Polen also serves on the Advisory Committee on Supply Chain Competitiveness for the U.S. Department of Commerce’s International Trade Administration. Polen holds a bachelor’s degree from Salisbury University and a master’s in business administration from Johns Hopkins University.
Personal Details
Qualifications & Experience
Other directorships (state)
(only entities turnover at least $5m p/a)
Working history
Committee/s
| Company | Committee | Role | Appointment Date | Resignation Date |
|---|---|---|---|---|
| Walgreens | Board | Member | 01/01/2023 |